Select Publications
Journal articles
2024, 'Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohort', Health and Quality of Life Outcomes, 22, http://dx.doi.org/10.1186/s12955-023-02225-8
,2024, 'A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung Cancer', JTO Clinical and Research Reports, 5, http://dx.doi.org/10.1016/j.jtocrr.2024.100633
,2024, '“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders', Translational Lung Cancer Research, 13, pp. 240 - 255, http://dx.doi.org/10.21037/tlcr-23-623
,2024, 'The TSANZ and Lung Foundation Australia 2023 landscape survey of lung cancer care across Australia and Aotearoa New Zealand', Respirology, http://dx.doi.org/10.1111/resp.14693
,2023, 'Implementing Smoking Cessation Interventions for Tobacco Users Within Oncology Settings: A Systematic Review', JAMA Oncology, 9, pp. 981 - 1000, http://dx.doi.org/10.1001/jamaoncol.2023.0031
,2023, 'Advances in lung cancer: a ground-breaking decade', The Lancet Respiratory Medicine, 11, pp. 407 - 409, http://dx.doi.org/10.1016/S2213-2600(23)00133-9
,2023, '"What do i think about implementing lung cancer screening? It all depends on how." Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0283939
,2023, 'Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A systematic review', Preventive Medicine, 169, http://dx.doi.org/10.1016/j.ypmed.2023.107459
,2023, 'Lung cancer screening: The hidden public health emergency', Public Health Research and Practice, 33, http://dx.doi.org/10.17061/phrp3312302
,2023, 'Lung cancer screening', The Lancet, 401, pp. 390 - 408, http://dx.doi.org/10.1016/S0140-6736(22)01694-4
,2023, 'Economic impact of using risk models for eligibility selection to the International lung screening Trial', Lung Cancer, 176, pp. 38 - 45, http://dx.doi.org/10.1016/j.lungcan.2022.12.011
,2023, 'A Systematic Review of Electronic Medical Record Driven Quality Measurement and Feedback Systems', International Journal of Environmental Research and Public Health, 20, http://dx.doi.org/10.3390/ijerph20010200
,2023, 'An update on long COVID and its management', Medicine Today, 24, pp. 37 - 43
,2023, 'Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors’ experiences of ongoing physical effects, novel treatments, uncertainty, and coping', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-023-01417-x
,2023, 'Building on a Legacy', JTO Clinical and Research Reports, 4, http://dx.doi.org/10.1016/j.jtocrr.2022.100445
,2023, 'Lung Cancer Screening: Implementation Challenges and Health Equity Considerations For the Western Pacific Region', JCO global oncology, 9, pp. e2200329, http://dx.doi.org/10.1200/GO.22.00329
,2023, 'Recreational vaping ban in Australia—policy failure or masterstroke?', The Lancet, http://dx.doi.org/10.1016/S0140-6736(23)02298-5
,2023, 'Accelerating implementation of lung cancer screening in Australia: what evidence-based strategies are recommended?', Lung Cancer, 178, pp. S66 - S66, http://dx.doi.org/10.1016/s0169-5002(23)00579-2
,2023, 'EP17.01-01 The Lung Cancer Clinical Quality Data Platform (LUCAP): Results from a Western Australia Pilot Study', Journal of Thoracic Oncology, 18, pp. S733 - S734, http://dx.doi.org/10.1016/j.jtho.2023.09.1418
,2023, 'EP17.01-05 Lung Cancer (Internet-Based) Delphi (LuCiD): a Delphi Consensus to Develop Australasian Thoracic Oncology Quality Indicators', Journal of Thoracic Oncology, 18, pp. S735 - S736, http://dx.doi.org/10.1016/j.jtho.2023.09.1422
,2023, 'MA03.09 Embedding Smoking Cessation into a Potential Lung Cancer Screening Program: Australian Tobacco Control Expert Perspectives', Journal of Thoracic Oncology, 18, pp. S108 - S108, http://dx.doi.org/10.1016/j.jtho.2023.09.133
,2023, 'P1.01-12 “A Core Part of the Whole Thing...”: Stakeholder Views on Offering Smoking Cessation Support in Lung Cancer Screening', Journal of Thoracic Oncology, 18, pp. S186 - S187, http://dx.doi.org/10.1016/j.jtho.2023.09.290
,2022, 'Contemporary Concise Review 2021: Pulmonary nodules from detection to intervention', Respirology, 27, pp. 776 - 785, http://dx.doi.org/10.1111/resp.14296
,2022, 'Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0275361
,2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010
,2022, 'The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics', Current Oncology, 29, pp. 6325 - 6333, http://dx.doi.org/10.3390/curroncol29090497
,2022, 'Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-060907
,2022, 'Sustaining the Australian respiratory workforce through the COVID-19 pandemic: a scoping literature review', Internal Medicine Journal, 52, pp. 1115 - 1122, http://dx.doi.org/10.1111/imj.15718
,2022, 'Hospital-based multidisciplinary lung cancer care in Australia: A survey of the landscape in 2021', BMJ Open Respiratory Research, 9, http://dx.doi.org/10.1136/bmjresp-2021-001157
,2022, 'USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study', The Lancet Oncology, 23, pp. 138 - 148, http://dx.doi.org/10.1016/S1470-2045(21)00590-8
,2022, 'EP01.02-004 Education Messages and Strategies About Lung Cancer Screening: A Systematic Review', Journal of Thoracic Oncology, 17, pp. S168 - S168, http://dx.doi.org/10.1016/j.jtho.2022.07.278
,2022, 'EP01.03-006 Potential Drivers of Lung Cancer Screening Participation in Australia: A Qualitative Study to Inform Future Implementation', Journal of Thoracic Oncology, 17, pp. S174 - S174, http://dx.doi.org/10.1016/j.jtho.2022.07.288
,2022, 'EP01.03-012 Acceptability and Feasibility of Lung Cancer Screening in Australia: The View of Key Stakeholders', Journal of Thoracic Oncology, 17, pp. S177 - S177, http://dx.doi.org/10.1016/j.jtho.2022.07.294
,2022, 'EP10.01-005 Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', Journal of Thoracic Oncology, 17, pp. S502 - S502, http://dx.doi.org/10.1016/j.jtho.2022.07.882
,2021, 'Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres', Implementation Science, 16, pp. 23, http://dx.doi.org/10.1186/s13012-021-01092-5
,2021, 'Variations in lung cancer care and outcomes: How best to identify and improve standards of care?', Respirology, 26, pp. 1103 - 1105, http://dx.doi.org/10.1111/resp.14155
,2021, 'Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.701424
,2021, 'Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships', Journal of Thoracic Oncology, 16, pp. 706 - 708, http://dx.doi.org/10.1016/j.jtho.2021.03.005
,2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963
,2021, 'OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results', Journal of Thoracic Oncology, 16, pp. S881 - S881, http://dx.doi.org/10.1016/j.jtho.2021.08.097
,2021, 'P41.07 Lung Cancer Screening: What is the State of the Evidence about Implementation?', Journal of Thoracic Oncology, 16, pp. S475 - S475, http://dx.doi.org/10.1016/j.jtho.2021.01.821
,2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960
,2020, 'Essential update in lung cancer medicine', Respirology, 25, pp. 3 - 4, http://dx.doi.org/10.1111/resp.13968
,2020, 'Medicolegal Considerations in Multidisciplinary Cancer Care', JTO Clinical and Research Reports, 1, http://dx.doi.org/10.1016/j.jtocrr.2020.100073
,2020, 'Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*', Respirology, 25, pp. 1082 - 1089, http://dx.doi.org/10.1111/resp.13904
,2020, 'Multidisciplinary team care in lung cancer', Translational Lung Cancer Research, 9, pp. 1625 - 1628, http://dx.doi.org/10.21037/tlcr-2020-lcmc-08
,2020, 'Optimizing lung cancer MDT data for maximum clinical impact-a scoping literature review', Translational Lung Cancer Research, 9, pp. 1629 - 1638, http://dx.doi.org/10.21037/tlcr.2020.01.02
,2020, 'Molecular testing of metastatic non-small cell lung cancer in the Asia-Pacific region', Respirology, 25, pp. 685 - 687, http://dx.doi.org/10.1111/resp.13833
,2020, 'Clinical impact of data feedback at lung cancer multidisciplinary team meetings: A mixed methods study', Asia-Pacific Journal of Clinical Oncology, 16, pp. 45 - 55, http://dx.doi.org/10.1111/ajco.13278
,2020, 'Protocol and rationale for the international lung screening trial', Annals of the American Thoracic Society, 17, pp. 503 - 512, http://dx.doi.org/10.1513/AnnalsATS.201902-102OC
,